2 results
Approved WMOCompleted
Primary * To evaluate the efficacy of SAR245409 as determined by the objective response rate (ORR) in patients with 1 of the following relapsed or refractory lymphoma or leukemia subtypes: mantle cell lymphoma (MCL), follicular lymphoma (FL), or…
Approved WMOPending
To assess the effectiveness of pacing therapy for preventing syncope recurrence inpatients with a high probability of neurally-mediated syncope different from carotid sinus syndrome.